                                                                                                                                   I




                                  113TH CONGRESS
                                     1ST SESSION                          H. R. 594
                                        To reauthorize and extend the Paul D. Wellstone Muscular Dystrophy
                                        Community Assistance, Research, and Education Amendments of 2008.




                                                IN THE HOUSE OF REPRESENTATIVES
                                                                 FEBRUARY 8, 2013
                                       Mr. BURGESS (for himself and Mr. ENGEL) introduced the following bill;
                                           which was referred to the Committee on Energy and Commerce




                                                                            A BILL
                                  To reauthorize and extend the Paul D. Wellstone Muscular
                                     Dystrophy Community Assistance, Research, and Edu-
                                     cation Amendments of 2008.
                                    1              Be it enacted by the Senate and House of Representa-
                                    2 tives of the United States of America in Congress assembled,
                                    3     SECTION 1. SHORT TITLE.
                                    4              This Act may be cited as the ‘‘Paul D. Wellstone
                                    5 Muscular Dystrophy Community Assistance, Research and
                                    6 Education Amendments of 2013’’.
                                    7     SEC. 2. INITIATIVE THROUGH THE DIRECTOR OF THE NA-
                                    8                             TIONAL INSTITUTES OF HEALTH.
                                    9              Section 404E of the Public Health Service Act (42
                                  10 U.S.C. 283g) is amended—

                                                                                             2
                                    1                        (1) in subsection (a)(1)—
                                    2                                 (A) by striking ‘‘Muscoskeletal’’ and in-
                                    3                        serting ‘‘Musculoskeletal’’; and
                                    4                                 (B)         by     inserting             ‘‘Becker,           myotonic,
                                    5                        facioscapulohumeral muscular dystrophy (re-
                                    6                        ferred to in this section as ‘FSHD’), Congenital
                                    7                        muscular dystrophy, Limb-girdle muscular dys-
                                    8                        trophy,’’ after ‘‘Duchenne,’’;
                                    9                        (2) in subsection (b)—
                                  10                                  (A) in paragraph (2), by inserting ‘‘cardiac
                                  11                         and pulmonary function,’’ after ‘‘imaging, ge-
                                  12                         netics,’’; and
                                  13                                  (B) in paragraph (3), by inserting ‘‘and
                                  14                         sharing of data’’ after ‘‘regular communica-
                                  15                         tion’’;
                                  16                         (3) in subsection (d)—
                                  17                                  (A) in paragraph (2)—
                                  18                                         (i) in the matter preceding subpara-
                                  19                                  graph (A), by striking ‘‘15’’ and inserting
                                  20                                  ‘‘18’’; and
                                  21                                         (ii) in subparagraph (A), by striking
                                  22                                  ‘‘children with muscular dystrophy, such as
                                  23                                  the Department of Education’’ and insert-




                                  24                                  ing ‘‘children and adults with muscular
                                  25                                  dystrophy, such as the Department of


                                              •HR 594 IH

                                                                                             3
                                    1                                 Education, the Social Security Administra-
                                    2                                 tion, the United States Administration for
                                    3                                 Community Living’’; and
                                    4                                 (B) in paragraph (4)(B), by inserting ‘‘,
                                    5                        and shall meet no less than two times per cal-
                                    6                        endar year’’ before the period;
                                    7                        (4) in subsection (e)—
                                    8                                 (A) in paragraph (1)—
                                    9                                        (i) in the matter preceding subpara-
                                  10                                  graph (A), by striking ‘‘through the na-
                                  11                                  tional research institutes’’ and inserting
                                  12                                  ‘‘through the agencies represented on the
                                  13                                  Coordinating Committee pursuant to sub-
                                  14                                  section (d)(2)(A)’’; and
                                  15                                         (ii) in subparagraph (A), by striking
                                  16                                  ‘‘and rehabilitative issues, including studies
                                  17                                  of the impact of such diseases in rural and
                                  18                                  underserved communities’’ and inserting
                                  19                                  ‘‘public resources, and rehabilitative issues,
                                  20                                  including studies of the impact of such dis-
                                  21                                  eases in rural and underserved commu-
                                  22                                  nities, health economic studies to dem-
                                  23                                  onstrate the cost-effectiveness of providing




                                  24                                  independent living resources and support
                                  25                                  to patients with various forms of muscular


                                              •HR 594 IH

                                                                                             4
                                    1                                 dystrophy, and studies to determine opti-
                                    2                                 mal clinical care interventions for adults
                                    3                                 with various forms of muscular dys-
                                    4                                 trophy’’; and
                                    5                                 (B) in paragraph (2), by adding at the end
                                    6                        the following:
                                    7                                 ‘‘(F) The development of clinical interven-
                                    8                        tions to improve the health of adults with var-
                                    9                        ious forms of muscular dystrophy.’’; and
                                  10                         (5) in subsection (g), by striking ‘‘for the var-
                                  11               ious forms of muscular dystrophy by prioritizing the
                                  12               achievement of the goals related to this topic in the
                                  13               plan under subsection (e)(1)’’ and inserting ‘‘and
                                  14               shall, not later than 6 months after the date of en-
                                  15               actment of the Paul D. Wellstone Muscular Dys-
                                  16               trophy Community Assistance, Research and Edu-
                                  17               cation Amendments of 2013, in coordination with
                                  18               appropriate Federal agencies, including relevant of-
                                  19               fices within the Food and Drug Administration and
                                  20               supported by the National Institutes of Health and
                                  21               Department of Defense, develop a plan to expedite
                                  22               the evaluation and approval of emerging therapies
                                  23               and personalized medicines that have the potential




                                  24               to decrease fatal disease progression across the var-
                                  25               ious forms of muscular dystrophy’’.


                                              •HR 594 IH

                                    1     SEC. 3. SURVEILLANCE AND RESEARCH REGARDING MUS-   5
                                    2                             CULAR DYSTROPHY.
                                    3              Section 317Q of the Public Health Service Act (42
                                    4 U.S.C. 247b–18) is amended—
                                    5                        (1) in the second sentence of subsection (b), by
                                    6              inserting before the period the following: ‘‘and en-
                                    7              sure that the program captures data from different
                                    8              racial and ethnic populations, and that such data
                                    9              are made publicly available to investigators con-
                                  10               ducting public or private research on muscular dys-
                                  11               trophy’’; and
                                  12                         (2) in subsection (c), by adding at the end the
                                  13               following: ‘‘The Secretary shall also foster ongoing
                                  14               engagement and collaboration between the surveil-
                                  15               lance program and centers of excellence.’’.
                                  16      SEC. 4. INFORMATION AND EDUCATION.
                                  17               Section 5(c) of the Muscular Dystrophy Community
                                  18 Assistance, Research and Education Amendments of 2001
                                  19 (42 U.S.C. 247b–19(c)) is amended by adding at the end
                                  20 the following:
                                  21                         ‘‘(4) Update and widely disseminate existing
                                  22               Duchenne-Becker muscular dystrophy care consider-
                                  23               ations for pediatric patients, develop and widely dis-
                                  24               seminate Duchenne-Becker muscular dystrophy care




                                  25               considerations for adult patients, and develop and
                                  26               widely disseminate acute care considerations for all
                                              •HR 594 IH

                                                                                             6
                                    1              muscular dystrophy populations. The care consider-
                                    2              ations should build upon existing efforts currently
                                    3              underway               for       congenital               muscular              dystrophy,
                                    4              fascioscapulohumeral muscular dystrophy, limb-gir-
                                    5              dle muscular dystrophy, and myotonic muscular dys-
                                    6              trophy, and incorporate strategies specifically re-
                                    7              sponding to the findings of the national transitions
                                    8              survey of minority, young adult and adult commu-
                                    9              nities of muscular dystrophy patients.’’.
                                              •HR 594 IH                                   Æ
